Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18183InvestigationalProtein Based Therapies
NBL-015: Overview.
- Also known as
- Fully human monoclonal IgG1 antibody against the type 2 isoform of human Claudin 18 protein (Claudin 18.2). · NBL-015 (ANTI-CLAUDIN18.2 MAB)
- Code names
- FL-301 · NBL 015
Resolves to
Compound
What you can answer from here — as of September 21, 2023
Which companies are running trials of NBL-015, in which indications and phases, and which of those programs are still active?